Screening for symptoms of restless… for Parkinson's (NCT06684782)
Measure restless leg syndrome prevalence
- Trial ID
- NCT06684782
- Official Title
- Prevalence and Characteristics of Restless Leg Syndrome in Thai Patients With Parkinson's Disease
- Goal
- Measure restless leg syndrome prevalence
- Status
- RECRUITING
- Sponsor
- Siriraj Hospital
- Study Type
- OBSERVATIONAL
- Enrollment
- 310 participants
- Conditions
- Restless Legs Syndrome
- Interventions
- Screening for symptoms of restless leg syndrome
Summary For Families
They aim to find how common restless legs syndrome is and what its typical symptoms and patterns look like in Thai people with Parkinson's. Participants will be screened for restless leg symptoms and clinical characteristics so researchers can map prevalence and how RLS relates to Parkinson's features, rather than testing a treatment. Adults 18 to 80 with Parkinson's who meet the UKPDS Brain Bank criteria and have an MMSE of 24 or higher are eligible, while people with atypical or secondary parkinsonism or other causes of RLS such as end-stage kidney disease, iron deficiency anemia, or pregnancy are excluded.
Locations
- Siriraj Hospital, Mahidol University, Bangkok, Bangkok, Thailand
- Siriraj Hospital, Mahidol University, Bangkok, Thailand, Thailand
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Screening for symptoms of restless leg syndrome. They aim to find how common restless legs syndrome is and what its typical symptoms and patterns look like in Thai people with Parkinson's. Participants will be screened for restless leg symptoms and clinical characteristics so researchers can map prevalence and how RLS relates to Parkinson's features, rather than testing a treatment. Adults 18 to 80 with Parkinson's who meet the UKPDS Brain Bank criteria and have an MMSE of 24 or higher are eligible, while people with atypical or secondary parkinsonism or other causes of RLS such as end-stage kidney disease, iron deficiency anemia, or pregnancy are excluded.
- Who can participate?
- Participants must be between 18 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 2 locations.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 11 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This is an observational study, so there is no placebo and no experimental treatment is assigned. Researchers observe and collect information while you continue your usual care.
- What procedures are involved in this trial?
- Based on the protocol, this trial involves: Questionnaires & surveys (non-invasive). Confirm the full schedule with the study coordinator.